BioRender 아이콘

Cytotoxic T cell (with granules, attacking)

Cytotoxic T cell (with granules, attacking) - Editable icon of an attacking, circular cytotoxic t cell with a circular nucleus, shown reaching outwards with granules collecting in the outward appendage
[{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c00bd2ded00211ea457/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c00bd2ded00211ea457/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c00bd2ded00211ea456/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c00bd2ded00211ea456/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea489/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea489/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea488/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea488/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea487/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea487/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea486/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea486/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea485/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea485/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea484/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea484/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea483/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea483/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea482/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea482/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea481/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea481/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea480/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea480/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea47f/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea47f/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea47e/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea47e/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea47d/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea47d/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea47c/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea47c/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea47b/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea47b/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea47a/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea47a/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea479/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea479/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea478/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea478/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea477/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea477/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea476/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea476/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea475/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea475/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea474/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea474/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea473/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea473/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea472/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea472/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea471/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea471/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea470/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea470/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea46f/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea46f/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea46e/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea46e/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea46d/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea46d/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea46c/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea46c/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea46b/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea46b/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea46a/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea46a/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea469/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea469/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea468/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea468/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea467/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea467/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea466/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea466/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea465/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea465/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea464/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea464/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea463/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea463/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea462/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea462/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea461/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea461/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea460/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea460/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea45f/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea45f/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea45e/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea45e/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea45d/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea45d/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea45c/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea45c/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea45b/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea45b/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea45a/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea45a/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea459/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea459/63d948f7bd2ded00211ea43e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/63d94c0abd2ded00211ea458/63d948f7bd2ded00211ea43e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/63d94c0abd2ded00211ea458/63d948f7bd2ded00211ea43e.png"}]
이 아이콘 사용하기 – 무료
가입 시 신용카드가 필요하지 않습니다.

이 아이콘은 BioRender에서 자유롭게 편집할 수 있습니다

  • 텍스트, 도형 및 기타 아이콘 추가
  • 5만 개 이상의 과학적으로 정확한 아이콘을 검색하세요
  • 모든 아이콘, 선, 라벨의 색상과 배치를 자유롭게 변경하세요
  • 어떤 용도로든 내보내거나 공유하세요
Scientist Avatars

이미 출판용 수준의 그림을 만들고 있는 400만 명 이상의 과학자들과 함께하세요

아이콘으로 몇 분 만에 완성된 그림을 만들어 보세요

  • 검색 50,000개 이상의 과학적으로 정확하고 동료 검토를 거친 아이콘 제공
  • 맞춤 설정 라벨, 도형, 추가 아이콘을 사용하여 모든 요소를 자유롭게 편집할 수 있습니다.
  • 내보내기 또는 공동 작업자와 그림 공유하기
    ‍

찾으시는 아이콘이 아닌가요? 더 많은 아이콘을 확인해 보세요.

30개 이상의 생명과학 분야에 걸친 50,000개 이상의 아이콘을 검색하세요.

search icon
arrow-right
cytotoxic,CTL,T cell,T-cell,tcell,granules,Tc,cytotoxic T lymphocyte,T lymphocyte,T-killer cell,killer cell,killer T cell,cytolytic T cell,CD8+ T-cell,CD8,t cell activation,activated,attack,attacking,lymphocyte,white blood cell,WBC,killer cell,killer t cell,outward,extension,appendage,immune cell,immune system,immune response,immunity,immunology,adaptive immune system,cancer,cancer treatment,foreign cells,infection,viral infection,antigen recognition,differentiated,target cell,pathogen destruction,cytotoxic granules,apoptosis,proj-icon-suggestions-22q4,proj-icon-suggestions-22q4-pathology,cytotoxic,CTL,t cell
더 보기

동의어를 검색하거나 가입하여 앱에서 아이콘을 요청해 보세요.

이미지 유형

Cytotoxic T cell (with granules, attacking) icon JPEG

Cytotoxic T cell (with granules, attacking) icon PNG

Cytotoxic T cell (with granules, attacking) icon SVG

Cytotoxic T cell (with granules, attacking) icon GIF

BioRender 아이콘 FAQ

How are scientists using the Cytotoxic T cell (with granules, attacking) icon in their work?

BioRender users often use the Cytotoxic T cell (with granules, attacking) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

이 아이콘을 BioRender 그림이나 과학 일러스트레이션에 사용할 수 있나요?

Yes, the Cytotoxic T cell (with granules, attacking) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Cytotoxic T cell (with granules, attacking) icon customizable in BioRender?

Most icons in BioRender, including the Cytotoxic T cell (with granules, attacking) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Cytotoxic T cell (with granules, attacking) icon for publication or presentations?

Yes, figures containing the Cytotoxic T cell (with granules, attacking) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Cytotoxic T cell (with granules, attacking) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Cytotoxic T cell (with granules, attacking) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

BioRender란 무엇인가요?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Cytotoxic T cell (with granules, attacking) icon along with our library of more than 30,000 life science icons.

BioRender에서 이 아이콘 사용하기

지금 바로 전문가 수준의 과학 피규어를 만들어 보세요
antibody elements3D Phospholipid illustration

과학 콘텐츠를 찾고 계신가요?

동료 검토를 거쳐 사용하기 쉽고 무료로 제공되는 5만 개 이상의 아이콘과 템플릿을 살펴보세요.

지금 바로 찾아보세요
x icon